Literature DB >> 18716219

Knock-in mice lacking the PDZ-ligand motif of mGluR7a show impaired PKC-dependent autoinhibition of glutamate release, spatial working memory deficits, and increased susceptibility to pentylenetetrazol.

Chuan-Sheng Zhang1, Federica Bertaso, Volker Eulenburg, Mireille Lerner-Natoli, Greta Ann Herin, Liane Bauer, Joel Bockaert, Laurent Fagni, Heinrich Betz, Astrid Scheschonka.   

Abstract

The metabotropic glutamate receptor 7 (mGluR7) is widely expressed throughout the brain and primarily localized at presynaptic active zones, where it is thought to regulate neurotransmitter release. Protein interacting with C kinase 1 (PICK1), a postsynaptic density protein-95/disc-large tumor suppressor protein/zonula occludens-1 (PDZ)-domain protein, binds to the three C-terminal amino acids (-LVI) of the predominant mGluR7 splice variant, mGluR7a, and has been implicated in the synaptic clustering of this receptor. Here, we generated knock-in mice in which the C-terminal LVI coding sequence of exon 10 of the mGluR7 gene was replaced by three alanine codons (-AAA). Immunoprecipitation showed that the PICK1-mGluR7a interaction is disrupted in mGluR7a(AAA/AAA) mice. However, the synaptic localization of mGluR7a was not altered in cultured hippocampal neurons and brain sections prepared from the knock-in animals. In cerebellar granule cell cultures, the group III mGluR agonist l-AP-4 decreased the frequency of spontaneous excitatory currents in neurons derived from wild-type but not mGluR7a(AAA/AAA) mice, consistent with the interaction between mGluR7a and PICK1 being required for protein kinase C-mediated inhibition of glutamate release. At the behavioral level, the mGluR7a(AAA/AAA) mice showed no deficits in motor coordination, pain sensitivity, and anxiety but exhibited significant defects in hippocampus-dependent spatial working memory. In addition, they displayed a high susceptibility to the convulsant drug pentylenetetrazole. Together, these results indicate that PICK1 binding to the C-terminal region of mGluR7a is crucial for agonist-triggered presynaptic signaling in vivo.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18716219      PMCID: PMC6671056          DOI: 10.1523/JNEUROSCI.0628-08.2008

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  46 in total

1.  Long-term depression in hippocampal interneurons: joint requirement for pre- and postsynaptic events.

Authors:  F Laezza; J J Doherty; R Dingledine
Journal:  Science       Date:  1999-08-27       Impact factor: 47.728

2.  Presynaptic clustering of mGluR7a requires the PICK1 PDZ domain binding site.

Authors:  H Boudin; A Doan; J Xia; R Shigemoto; R L Huganir; P Worley; A M Craig
Journal:  Neuron       Date:  2000-11       Impact factor: 17.173

Review 3.  PDZ domains: structural modules for protein complex assembly.

Authors:  Albert Y Hung; Morgan Sheng
Journal:  J Biol Chem       Date:  2001-12-10       Impact factor: 5.157

4.  Molecular determinants for PICK1 synaptic aggregation and mGluR7a receptor coclustering: role of the PDZ, coiled-coil, and acidic domains.

Authors:  H Boudin; A M Craig
Journal:  J Biol Chem       Date:  2001-05-24       Impact factor: 5.157

5.  Selective blockade of P/Q-type calcium channels by the metabotropic glutamate receptor type 7 involves a phospholipase C pathway in neurons.

Authors:  J Perroy; L Prezeau; M De Waard; R Shigemoto; J Bockaert; L Fagni
Journal:  J Neurosci       Date:  2000-11-01       Impact factor: 6.167

6.  Increased seizure susceptibility in mice lacking metabotropic glutamate receptor 7.

Authors:  G Sansig; T J Bushell; V R Clarke; A Rozov; N Burnashev; C Portet; F Gasparini; M Schmutz; K Klebs; R Shigemoto; P J Flor; R Kuhn; T Knoepfel; M Schroeder; D R Hampson; V J Collett; C Zhang; R M Duvoisin; G L Collingridge; H van Der Putten
Journal:  J Neurosci       Date:  2001-11-15       Impact factor: 6.167

7.  (R,S)-4-phosphonophenylglycine, a potent and selective group III metabotropic glutamate receptor agonist, is anticonvulsive and neuroprotective in vivo.

Authors:  F Gasparini; V Bruno; G Battaglia; S Lukic; T Leonhardt; W Inderbitzin; D Laurie; B Sommer; M A Varney; S D Hess; E C Johnson; R Kuhn; S Urwyler; D Sauer; C Portet; M Schmutz; F Nicoletti; P J Flor
Journal:  J Pharmacol Exp Ther       Date:  1999-06       Impact factor: 4.030

8.  Calmodulin dependence of presynaptic metabotropic glutamate receptor signaling.

Authors:  V O'Connor; O El Far; E Bofill-Cardona; C Nanoff; M Freissmuth; A Karschin; J M Airas; H Betz; S Boehm
Journal:  Science       Date:  1999-11-05       Impact factor: 47.728

9.  Interaction of the C-terminal tail region of the metabotropic glutamate receptor 7 with the protein kinase C substrate PICK1.

Authors:  O El Far; J Airas; E Wischmeyer; R B Nehring; A Karschin; H Betz
Journal:  Eur J Neurosci       Date:  2000-12       Impact factor: 3.386

10.  PICK1 interacts with and regulates PKC phosphorylation of mGLUR7.

Authors:  K K Dev; Y Nakajima; J Kitano; S P Braithwaite; J M Henley; S Nakanishi
Journal:  J Neurosci       Date:  2000-10-01       Impact factor: 6.167

View more
  21 in total

1.  Prenatal Alcohol Exposure Increases Histamine H3 Receptor-Mediated Inhibition of Glutamatergic Neurotransmission in Rat Dentate Gyrus.

Authors:  Rafael K Varaschin; Nyika A Allen; Martina J Rosenberg; C Fernando Valenzuela; Daniel D Savage
Journal:  Alcohol Clin Exp Res       Date:  2018-01-08       Impact factor: 3.455

2.  Modulation of short-term plasticity in the corticothalamic circuit by group III metabotropic glutamate receptors.

Authors:  Christine L Kyuyoung; John R Huguenard
Journal:  J Neurosci       Date:  2014-01-08       Impact factor: 6.167

Review 3.  Progress toward advanced understanding of metabotropic glutamate receptors: structure, signaling and therapeutic indications.

Authors:  Shen Yin; Colleen M Niswender
Journal:  Cell Signal       Date:  2014-05-02       Impact factor: 4.315

Review 4.  Structure function relations in PDZ-domain-containing proteins: Implications for protein networks in cellular signalling.

Authors:  G P Manjunath; Praveena L Ramanujam; Sanjeev Galande
Journal:  J Biosci       Date:  2018-03       Impact factor: 1.826

5.  The metabotropic glutamate receptor mGlu7 activates phospholipase C, translocates munc-13-1 protein, and potentiates glutamate release at cerebrocortical nerve terminals.

Authors:  Ricardo Martín; Thierry Durroux; Francisco Ciruela; Magdalena Torres; Jean-Philippe Pin; José Sánchez-Prieto
Journal:  J Biol Chem       Date:  2010-04-07       Impact factor: 5.157

6.  Biallelic GRM7 variants cause epilepsy, microcephaly, and cerebral atrophy.

Authors:  Dana Marafi; Tadahiro Mitani; Sedat Isikay; Jozef Hertecant; Mohammed Almannai; Kandamurugu Manickam; Rami Abou Jamra; Ayman W El-Hattab; Jaishen Rajah; Jawid M Fatih; Haowei Du; Ender Karaca; Yavuz Bayram; Jaya Punetha; Jill A Rosenfeld; Shalini N Jhangiani; Eric Boerwinkle; Zeynep C Akdemir; Serkan Erdin; Jill V Hunter; Richard A Gibbs; Davut Pehlivan; Jennifer E Posey; James R Lupski
Journal:  Ann Clin Transl Neurol       Date:  2020-04-14       Impact factor: 4.511

Review 7.  Metabotropic glutamate receptors: physiology, pharmacology, and disease.

Authors:  Colleen M Niswender; P Jeffrey Conn
Journal:  Annu Rev Pharmacol Toxicol       Date:  2010       Impact factor: 13.820

Review 8.  Fine-tuning of GPCR activity by receptor-interacting proteins.

Authors:  Stefanie L Ritter; Randy A Hall
Journal:  Nat Rev Mol Cell Biol       Date:  2009-12       Impact factor: 94.444

9.  A genome-wide study of common SNPs and CNVs in cognitive performance in the CANTAB.

Authors:  Anna C Need; Deborah K Attix; Jill M McEvoy; Elizabeth T Cirulli; Kristen L Linney; Priscilla Hunt; Dongliang Ge; Erin L Heinzen; Jessica M Maia; Kevin V Shianna; Michael E Weale; Lynn F Cherkas; Gail Clement; Tim D Spector; Greg Gibson; David B Goldstein
Journal:  Hum Mol Genet       Date:  2009-09-04       Impact factor: 6.150

10.  Neurochemical and behavioral features in genetic absence epilepsy and in acutely induced absence seizures.

Authors:  A S Bazyan; G van Luijtelaar
Journal:  ISRN Neurol       Date:  2013-05-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.